Skip to content

A randomized controlled trial on the application of remimazolam in tooth extraction in elderly patients

A randomized controlled trial on the application of remimazolam in tooth extraction in elderly patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062344
Enrollment
Unknown
Registered
2022-08-02
Start date
2022-08-05
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental anxiety

Interventions

Group R: Intravenous Remimazolam
Group M:Intravenous midazolam

Sponsors

School of Stomatology, the Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients undergoing tooth extraction; Age 60 - 80 years old; 18 kg/m2<=BMI<=30kg/m2; ASA class I - III; Patient agrees and signs the informed consent form for clinical research.

Exclusion criteria

Exclusion criteria: History of nervous system; Patients with liver insufficiency, chronic or acute liver failure; Patients with renal insufficiency, chronic or acute renal failure; Myasthenia gravis patients; Have serious systemic diseases above ASA III; Known allergy to benzodiazepines or local anesthetics; Refuse treatment under sedation; Suspect or have a history of alcohol and drug abuse; Acute tooth extraction such as pericoronitis of wisdom teeth; Participated in other clinical trials in recent three months.

Design outcomes

Secondary

MeasureTime frame
Montreal Cognitive Assessment (MoCA);Time to peak sedation after administration of the first dose of medication;Sedation time;Procedure time;Awake time;Successful rate of sedation;Post-extraction bleeding ;Time to discharge;

Primary

MeasureTime frame
Montreal Cognitive Assessment (MoCA);

Countries

China

Contacts

Public ContactBing Liu

School of Stomatology, the Fourth Military Medical University

adalb729@163.com+86 136 0916 2972

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026